Utah Medical Products, Inc. (UTMD) Ownership
UTMD ownership summary
as of October 18, 2026- Institutions
- 76.6% of shares outstanding
- Insiders
- 7.18% of shares outstanding
- Shares outstanding
- 3.2M
- Float
- 2.8M shares available to trade
- Short interest
- 5.86% 152K shares short
- Days to cover
- 4.35 short interest down 11.8% vs prior month
- Institutions 76.60%
- Insiders 7.18%
- Other investors 16.22%
UTMD top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Brandes Investment Partners & Co | 14.97% | 475K | $35.4M | +25,879 (+5.8%) | June 30, 2026 |
| 2 | BlackRock Inc | 6.42% | 204K | $15.2M | +16,041 (+8.5%) | June 30, 2026 |
| 3 | Dimensional Fund Advisors, Inc. | 6.26% | 199K | $14.8M | +909 (+0.5%) | June 30, 2026 |
| 4 | Renaissance Technologies Corp | 5.54% | 176K | $13.1M | −8,300 (−4.5%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 4.24% | 135K | $10.0M | −4,025 (−2.9%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 3.40% | 108K | $8.1M | −12,049 (−10.0%) | June 30, 2026 |
| 7 | Minerva Advisors LLC | 2.95% | 94K | $7.0M | — | June 30, 2026 |
| 8 | Hotchkis & Wiley Capital Management LLC | 2.69% | 85K | $6.4M | −3,900 (−4.4%) | June 30, 2026 |
| 9 | Rice Hall James & Associates, LLC | 2.25% | 71K | $5.3M | +3,481 (+5.1%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | 2.20% | 70K | $5.2M | +20,870 (+42.8%) | June 30, 2026 |
| 11 | State Street Corp | 2.01% | 64K | $4.8M | −465 (−0.7%) | June 30, 2026 |
| 12 | Quantinno Capital Management LP | 1.36% | 43K | $3.2M | +13,233 (+44.3%) | June 30, 2026 |
| 13 | UBS Group AG | 1.08% | 34K | $2.6M | −2,547 (−6.9%) | June 30, 2026 |
| 14 | Bank of New York Mellon Corp | 1.08% | 34K | $2.6M | +2,181 (+6.8%) | June 30, 2026 |
| 15 | Northern Trust Corp | 0.95% | 30K | $2.2M | −188 (−0.6%) | June 30, 2026 |
| 16 | Huber Capital Management LLC | 0.91% | 29K | $2.2M | −6,906 (−19.2%) | June 30, 2026 |
| 17 | Cardinal Capital Management | 0.85% | 27K | $2.0M | +551 (+2.1%) | June 30, 2026 |
| 18 | Everett Harris & Co | 0.75% | 24K | $1.8M | −1,631 (−6.4%) | June 30, 2026 |
| 19 | T. Rowe Price Associates, Inc. | 0.69% | 22K | $1.6M | +3,638 (+19.9%) | June 30, 2026 |
| 20 | O'Shaughnessy Asset Management LLC | 0.68% | 22K | $1.6M | +396 (+1.9%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 87K shares and 9 cut 40K.
UTMD top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Brandes Small Cap Value R6 | 9.03% | 287K | $21.4M | +2,422 (+0.9%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 3.08% | 98K | $7.3M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 2.14% | 68K | $5.1M | −768 (−1.1%) | September 30, 2026 |
| 4 | Mediolanum BB Global Sm Cp Eq LA | 1.26% | 40K | $3.0M | +2,374 (+6.3%) | June 30, 2026 |
| 5 | DFA US Small Cap Value I | 1.24% | 39K | $2.9M | +2,448 (+6.7%) | August 31, 2026 |
| 6 | Fidelity Small Cap Index | 1.06% | 34K | $2.5M | +268 (+0.8%) | July 31, 2026 |
| 7 | DFA US Micro Cap I | 0.95% | 30K | $2.3M | — | August 31, 2026 |
| 8 | iShares Russell 2000 Value ETF | 0.82% | 26K | $1.9M | +40 (+0.2%) | September 30, 2026 |
| 9 | DFA US Targeted Value I | 0.69% | 22K | $1.6M | — | August 31, 2026 |
| 10 | Hotchkis & Wiley Sm Cp Divers Val I | 0.69% | 22K | $1.6M | — | August 31, 2026 |
| 11 | DFA US Small Cap I | 0.68% | 22K | $1.6M | — | August 31, 2026 |
| 12 | Dimensional US Targeted Value ETF | 0.60% | 19K | $1.4M | — | September 30, 2026 |
| 13 | WisdomTree US SmallCap Dividend ETF | 0.56% | 18K | $1.3M | +1,108 (+6.7%) | September 30, 2026 |
| 14 | Vanguard Russell 2000 ETF | 0.56% | 18K | $1.3M | +301 (+1.7%) | September 30, 2026 |
| 15 | Fidelity Extended Market Index | 0.45% | 14K | $1.1M | −76 (−0.5%) | August 31, 2026 |
| 16 | Dimensional US Small Cap Value ETF | 0.45% | 14K | $1.1M | — | September 24, 2026 |
| 17 | Huber Small Cap Value Inv | 0.41% | 13K | $967,810 | — | September 30, 2026 |
| 18 | U.S. Equity Small Cap Corporate Cl OF | 0.36% | 11K | $842,857 | — | June 30, 2026 |
| 19 | Dimensional US Small Cap ETF | 0.33% | 11K | $787,347 | — | September 30, 2026 |
| 20 | Chatrier Value Fund A CHF | 0.32% | 10K | $760,524 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
UTMD insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-18 | Paul O Richins | Sell | $93.47 | 700 | $65,429 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
UTMD shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns UTMD
Institutional investors own 76.6% of Utah Medical Products's shares and insiders 7.18%. The largest holder is Brandes Investment Partners & Co with 14.97% of the shares (475K), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 9 reduced their stake in the latest filings. Short interest is 5.86% of the float, or 4.35 days of average trading volume. The share count fell 15.2% since 2014.
Related: UTMD key metrics, UTMD dividend history. See the UTMD stock overview for the latest quote and news.
UTMD ownership FAQ
Who owns the most Utah Medical Products stock?
The largest shareholders of Utah Medical Products are Brandes Investment Partners & Co (14.97%), BlackRock Inc (6.42%), Dimensional Fund Advisors, Inc. (6.26%), Renaissance Technologies Corp (5.54%), Vanguard Capital Management, LLC (4.24%).
What percentage of Utah Medical Products is owned by institutions?
Institutions hold 76.6% of Utah Medical Products's shares outstanding; insiders hold 7.18%.
Which funds own Utah Medical Products?
The largest fund holders of Utah Medical Products are Brandes Small Cap Value R6 (9.03%), Vanguard MStar Total Stk Mkt Idx Invest (3.08%), iShares Russell 2000 ETF (2.14%), Mediolanum BB Global Sm Cp Eq LA (1.26%), DFA US Small Cap Value I (1.24%).
What is Utah Medical Products's short interest?
152K shares of Utah Medical Products were sold short, 5.86% of the float; at the average daily volume it would take 4.35 days to cover.
Are insiders buying or selling Utah Medical Products?
Of the latest 1 reported insider transactions in Utah Medical Products (since May 18, 2023), 0 were purchases and 1 were sales.
How many shares of Utah Medical Products are outstanding?
Utah Medical Products has 3.2M shares outstanding, of which 2.8M are in the public float.